In 2020, the urological device market size in China was valued at nearly $540 million, with over 2.4 million urological procedures performed every year. The market value is expected to increase at a compound annual growth rate (CAGR) of 1.7% to reach $605 million in 2026. Throughout this medical market research, we analyzed 49 urology companies
In 2020, the urological device market size in Japan was valued at $383 million, with over 540,000 urological procedures performed every year. The market size is expected to increase at a compound annual growth rate (CAGR) of 3.3% to reach $480 million in 2026. Throughout this medical market research, we analyzed 31 urology companies across
By 2020, the Brazilian urological device market size was valued at $663.6 million, with over 1.23 million urological procedures performed every year. The market value is expected to increase at a compound annual growth rate (CAGR) of 2.8% to reach $806 million in 2026. Throughout this medical market research, we analyzed 54 urology companies across
In 2020, the Australian urology market size was valued at nearly $72 million, with over 167,000 yearly urological procedures performed every year. The market size is expected to increase at a compound annual growth rate (CAGR) of 3% to reach nearly $89 million in 2026. Throughout this medical market research, we analyzed 31 urology companies
The market for urological endoscopes experienced the highest level of growth in 2015. This segment will continue to demonstrate a higher level of growth throughout the forecast period. Compared to other segments in the total market, the endoscope market will grow at rates more than three times faster, with the exception of one. Growth will
Overall, the U.S. urology market was valued at over $2.9 billion in 2018. This is expected to increase over the forecast period at a CAGR of 3.6% to reach $3.8 billion. As the demand side of the market continues to undergo consolidation, with hospitals acquiring outpatient facilities and expanding the reach of the group purchasing
Industry Trends In the U.S. urology market, the demand side of the market continues to undergo consolidation, with hospitals acquiring outpatient facilities and expanding the reach of the group purchasing organizations (GPOs), coupled with the reimbursement cuts across the urology space, average selling prices are expected to remain under significant pressure, negatively impacting the future
There are numerous methods for treating and removing kidney and urinary stones. Treatments can be classified as either extracorporeal or endoscopic stone management procedures. Extracorporeal shock wave lithotripsy (ESWL) treatment uses an ultrasound device to fragment the stone until it is small enough to be passed through the urethra. This is a non-invasive outpatient procedure that generally takes one hour to complete and is performed under local anesthesia. Typically, ESWL is used for small- to medium-sized stones between 1/6 inch and one inch in size. On average, stones re-form in 20% of ESWL patients because fragments are not completely excreted. Complications associated with ESWL include blocked urine flow from fragments in the urinary tract, bleeding and urinary tract infection. In addition, ESWL is rarely used on cystine kidney stones because these do not break up easily.
The European urology market includes the segments for TURP devices, laser BPH devices, brachytherapy, urinary catheters, nephrostomy devices, urinary incontinence slings, stone treatment devices, urological endoscopes and erectile dysfunction devices. As a whole the urological device market is very well established. This limits potential for substantial growth. Although companies continue to provide novel adaptations to their products, the general trend within the market is a slightly declining ASP. However, some segments are an exception to this lasers (for both BPH and stone management) have recently seen some exciting developments.
This report suite defines intracorporeal non-lithotripsy procedures as endoscopic removal of stones without fragmenting them first with ISWL. These procedures use retrieval devices such as alligator forceps or grasping forceps to crush the stone and remove the fragments or remove the stones whole. In addition, stone retrieval devices can be used to clinch the stone while treatment is being applied. The size, shape and location of the stone as well as the lithotripter being used are the primary determinants of which devices will be used. Stone retrieval devices can be segmented into two varieties based on their material. In the past, stainless-steel stone removal baskets were the standard. However, the emergence of the nitinol basket has shifted the market despite the cost premium.
The procedures covered in this report suite includes urinary incontinence, stone management, benign prostate hyperplasia (BPH), prostate cancer treatment, urodynamic testing, nephrostomy and erectile dysfunction management procedures. Each category is further segmented into more specific procedure types.
This report analyzes the markets for the treatment of benign prostate hyperplasia (BPH), prostate cancer, urinary incontinence as well as urinary and kidney stones. Other markets analyzed include urodynamic equipment and urological endoscopes. In 2012, the prostate cancer treatment device market was the second largest segment in the total Indian market for urological devices, almost doubling the stone treatment market. Procedural volume growth in the prostate cancer treatment device market is expected to increase over the 2012 to 2019 forecast period due to the expected rise in the aging population as well as increases in early diagnosis.